Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc

Bullboard Posts

Comment by Rickkieon Jun 27, 2016 10:28pm

83 Views

Post# 25003379

RE:RE:Good news?

Gamma, I was sure I read an excerpt (in quotes) from the Cormark report that someone posted where it made referernce to the 48% (or 52%). I have been searching for it but unable to find it. If in fact these numbers were never on the Cormark report, then mea culpa, it was not my intention to mislead.

Bullboard Posts

Government dispute forces Barrick Gold to suspend operations in Mali